HALT, pairs Amarna’s SV40-derived gene delivery vector platform with Phenocell’s in vitro AMD disease model, which accurately ...
Researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of ...
Iantrek’s CREST Registry reports 1-year outcomes for a bio-interventional glaucoma treatment, demonstrating significant IOP reduction, medication reduction, and a favorable safety profile, offering a ...
VisiRose, a company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of ...
EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...
Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...
ViaLase, John A. Moran Eye Center unveil research partnership to spark glaucoma research, innovation
According to the partners, glaucoma research to be led by internationally renowned glaucoma surgeon Ike Ahmed, MD, FRCSC, ...
Nona Biosciences has partnered with Kodiak Sciences to develop multi-target antibodies for ophthalmic diseases. Utilizing ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
A University of Colorado study links air pollution to increased ocular health issues, finding patient visits for irritation ...
It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...
The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback